An approach that could reduce the chances of drugs failing during the later stages of clinical trials has been demonstrated by a collaboration between the University of Cambridge and pharmaceutical company GlaxoSmithKline (GSK). CAMBRIDGE, 02-Jun-2016 — /EuropaWire/ — The technique involves … Read the full press release
Posted in Education, Healthcare, Science, United Kingdom
Tagged DNA encoding drug, GSK, Human genetics, Professor Nick Wareham, University of Cambridge
LONDON, 29-Mar-2016 — /EuropaWire/ — GlaxoSmithKline plc (LSE/NYSE:GSK) today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has granted approval for Nucala® (mepolizumab) as a treatment for bronchial asthma in patients with refractory asthma whose symptoms are inadequately … Read the full press release
London / UK, Schindellegi / CH, 13-1-2016 — /EuropaWire/ — Kuehne + Nagel and GSK signed an end-to-end global logistics partnership until 2021 that will see Kuehne + Nagel run the core business of transporting products from the raw materials … Read the full press release
LONDON, 11-1-2016 — /EuropaWire/ — ViiV Healthcare, a global specialist HIV company with GSK, Pfizer Inc. and Shionogi Limited as shareholders, today formalised its collaboration with Janssen Sciences Ireland UC (Janssen) for the phase III investigation and commercialisation of the … Read the full press release
Posted in Healthcare, Pharma & Biotech, Science, United Kingdom
Tagged GSK, HIV-1, Janssen Sciences Ireland UC, Pfizer Inc., Shionogi Limited, ViiV Healthcare
New hub based in Rockville, MD expands GSK’s global vaccines R&D footprint London and Philadelphia, 6-4-2015 — /EuropaWire/ — GSK announced today it is further strengthening and expanding its vaccines presence in the US by establishing a new global centre … Read the full press release
Posted in Healthcare, Management, Pharma & Biotech, Science, Technology, United Kingdom
Tagged global centre for vaccines R&D, GSK, Larry Hogan, Luc Debruyne, vaccines
14 proposals selected from 428 entries in 26 countries Project areas include HIV, cancer and neurodegeneration LONDON, 4-12-2014 — /EuropaWire/ — GSK has announced the winners of its second Discovery Fast Track Challenge – a programme designed to combine the … Read the full press release
Posted in Awards, Healthcare, Pharma & Biotech, Technology, United Kingdom
Tagged and Dr. Siobhan Malany, Discovery Fast Track Challenge, Dr Christos Chatziantoniou, Dr Federica Briani, Dr Geerten van Nieuw Amerongen, Dr John Burnett Jr, Dr Simon Wagner, Dr. Delphine Larrieu, Dr. Kilian Huber, Duncan Holmes, GSK, Prof Andrew Lever, Prof Giulio Superti-Furga, Prof Maureen Murphy, Prof Michael Marber, Prof Morris Brown, Prof Stefan Strack, Prof Steve Jackson, Prof Tania Watts, Prof Vanessa Sperandio, Prof. Donna George, Prof. Julia Leu
LONDON, 13-11-2014 — /EuropaWire/ — GSK today announced the submission to the European Medicines Agency (EMA) of a variation to the Marketing Authorisation for eltrombopag (Revolade™), seeking an additional indication for the treatment of adult patients with severe aplastic anaemia … Read the full press release
Posted in Healthcare, Marketing, Pharma & Biotech, United Kingdom
Tagged eltrombopag (Revolade™), EMA, European Medicines Agency, GSK, severe aplastic anaemia
Developers encouraged to request accelerated procedure for scientific advice LONDON, 30-10-2014 — /EuropaWire/ — The European Medicines Agency (EMA) has given scientific advice to GSK on its development plan for an Ebola vaccine. This is the first time in the … Read the full press release
LONDON, 9-10-2014 — /EuropaWire/ — Stiefel, a GSK company, today announced the start of a phase III study to evaluate the efficacy and safety of subcutaneous ofatumumab in patients with pemphigus vulgaris, a rare autoimmune skin disorder. The global study … Read the full press release
LONDON, 10-9-2014 — /EuropaWire/ — GSK today presented data at the European Respiratory Society (ERS) Congress that show blood eosinophil levels may help predict those patients with COPD who will have a greater reduction in exacerbation rates when receiving an … Read the full press release
LONDON, 10-9-2014 — /EuropaWire/ — GSK today announced a £5m collaboration with the UK and South African Medical Research Councils, to support much-needed research into non-communicable diseases (NCDs) in Africa, as part of GSK’s Africa NCD Open Lab initiative. The … Read the full press release
Marks GSK’s fourth Breakthrough Therapy designation London, UK, 17-1-2014 — /EuropaWire/ — GlaxoSmithKline plc (LSE: GSK) announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for Tafinlar®(dabrafenib) for treatment of patients with metastatic BRAF V600E … Read the full press release
London, UK, 23-10-2013 — /EuropaWire/ — GlaxoSmithKline plc (LSE:GSK) today announced the submission of a New Drug Application (NDA) in the US for the once daily inhaled corticosteroid (ICS) treatment, fluticasone furoate (FF), administered using the ELLIPTA™ dry powder inhaler. The NDA … Read the full press release
Posted in Government, Healthcare, Pharma & Biotech, Science, United Kingdom
Tagged asthma, Bradd Pavur, Catherine Hartley, David Daley, David Mawdsley, ELLIPTA™, ELLIPTA™ dry powder inhaler, fluticasone furoate (FF), fluticasone furoate monotherapy, Gary Davies, GlaxoSmithKline, GlaxoSmithKline plc, GSK, James Dodwell, Jeff McLaughlin, Juan Carlos Molina, Karen Collins, Kirsty Collins (SRI & CG), LSE:GSK, Lucy Singah, Melinda Stubbee, NDA, New Drug Application (NDA), once daily inhaled corticosteroid (ICS) treatment, Simon Steel, Stephen Rea, Tom Curry, US FDA, US regulatory submission, Ziba Shamsi
London, UK, 23-10-2013 — /EuropaWire/ — ViiV Healthcare today announced the submission of a regulatory application in the United States for its investigational single-tablet regimen (STR) combining dolutegravir, abacavir and lamivudine for the treatment of people living with HIV-1. This New Drug … Read the full press release
Posted in Government, Healthcare, Pharma & Biotech, Science, United Kingdom
Tagged abacavir, antiretroviral agents, David Daley, dolutegravir, Gary Davies, GlaxoSmithKline, GSK, HIV, HIV-1, James Dodwell, Jeff McLaughlin, lamivudine, Lucy Budd, Marc Meachem, Marketing Authorisation Application, Melinda Stubbee, New Drug Application (NDA), people living with HIV, Pfizer, Rebecca Hunt, single-tablet regimen, Tivicay®, Tom Curry, treatment of HIV-1, US Food and Drug Administration (FDA), US regulatory submission, ViiV Healthcare, Ziba Shamsi
22-7-2013 — /EuropaWire/ — Following a meeting with the Chinese Ministry of Public Security to discuss their investigation into GSK, Abbas Hussain, President International – Europe, Japan, Emerging Markets & Asia Pacific said: “We have had a very constructive meeting with the … Read the full press release
Posted in Business, Government, Healthcare, Management, Pharma & Biotech, United Kingdom
Tagged CHINA, Chinese authorities, Chinese law, Chinese Ministry of Public Security, corruption, GSK, GSK China
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
